Apalutamide and Overall Survival in Prostate Cancer
نویسندگان
چکیده
منابع مشابه
The impact of obesity on overall and cancer specific survival in men with prostate cancer.
PURPOSE We examined the impact of obesity on disease specific and overall survival in patients with prostate cancer. MATERIALS AND METHODS We identified 7,274 men from the Cancer of the Prostate Strategic Urological Research Endeavor database with clinically localized prostate cancer, known body mass index and clinicopathological disease characteristics. Patients were classified by body mass ...
متن کاملProstate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients.
We investigated the potential value of prostate-specific antigen half-life (PSAHL) and decreasing velocity (PSAVd) to predict progression-free survival (PFS) and overall survival (OS) in Chinese patients with prostate cancer. A total of 153 patients treated with hormonal therapy were included in the study. Of these, 78 patients progressed to hormone-refractory prostate cancer (HRPC) and 24 pati...
متن کاملProstate Cancer Overall Survival: Multilevel Analysis of A Population-Based Cancer Registry Data.
It has been estimated that there will be 233,000 new cases and 29,480 deaths from prostate cancer (PCa) in the United States in 2014.1 In 2014, the State of Florida ranks Second behind California in PCa incidence (16,590 estimated new cases).1 Second behind California for mortality (2,170 estimated deaths) from PCa.1 Few studies have investigated the contribution of individual-level and...
متن کاملCorrelation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients.
PURPOSE We constructed a biomarker-survival modeling framework to explore the relationship between prostate-specific antigen (PSA) kinetics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients following oral administration of 1,000 mg/day of abiraterone acetate (AA). EXPERIMENTAL DESIGN The PSA-survival modeling framework was based on data from two pha...
متن کاملAndrogen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival.
Several reports have suggested that one or both of the trinucleotide repeat polymorphisms in the human androgen receptor (hAR) gene, (CAG)n coding for polyglutamine and (GGC)n coding for polyglycine, may be associated with prostate cancer risk; but no study has investigated their association with disease progression. We present here a study of both hAR trinucleotide repeat polymorphisms not onl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Urology
سال: 2021
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2020.08.011